Author

Cihan Tastan

Uskudar University- Mol. Bio & Genetics - Cited by 329 - Gene Therapy - Rare Diseases - Microbiology - Gene Editing - Cancer Immunotherapy

Biography

Dr. Cihan Tastan is an Associate professor in the Department of Applied Transgenic Cell Technologies and Epigenetics, University of Uskudar, Istanbul located in Turkey. His major interests as “Bermuda Triangle” which has three intersections including Synthetic Biology, Immune system, and Microbiome.  
Title
Cited by
Year
Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation
C Tastan, E Karhan, W Zhou, E Fleming, AY Voigt, X Yao, L Wang, ...Mucosal immunology 11 (6), 1591-1605, 2018201
92
2018
Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics
B Berber, C Aydin, F Kocabas, G Guney-Esken, K Yilancioglu, ...Gene Therapy, 1, 2020202
40
2020
Functional Interrogation of Primary Human T Cells via CRISPR Genetic Editing
X Chen, L Kozhaya, C Tastan, L Placek, M Dogan, M Horne, R Abblett, ...The Journal of Immunology 201 (5), 1586-1598, 2018201
39
2018
Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection
HK Okur, K Yalcin, C Tastan, S Demir, B Yurtsever, GS Karakus, ...New microbes and new infections , 100756, 2020202
37
2020
HIV-infected children have lower frequencies of CD8+ mucosal-associated invariant T (MAIT) cells that correlate with innate, Th17 and Th22 cell subsets
A Khaitan, M Kilberg, A Kravietz, T Ilmet, C Tastan, M Mwamzuka, ...PLoS One 11 (8), e0161786, 2016201
30
2016
SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients
C TaŞtan, B Yurtsever, G KARAKUŞ, DDİ KanÇaĞi, S Demir, S Abanuz, ...Turkish Journal of Biology 44 (7), 192-202, 2020202
29
2020
Anti-cancer effect of metformin on the metastasis and invasion of primary breast cancer cells through mediating NF-kB activity
G Yenmis, EY Sarac, N Besli, T Soydas, C Tastan, DD Kancagi, M Yilanci, ...Acta Histochemica 123 (4), 151709, 2021202
19
2021
Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates
G Karakus, C Tastan, D Dilek Kancagi, B Yurtsever, G Tumentemur, ...Scientific reports 11 (1), 1-19, 202114202
14
2021
Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61. 3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice
RD Turan, C Tastan, D Dilek Kancagi, B Yurtsever, G Karakus, S Ozer, ...Scientific reports 11 (1), 1-16, 2021202
9
2021
Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) targeting CD19-expressing B Cells for the First Turkish Academic Clinical Trial with Relapsed …
C Taştan, DD Kancagi, RD Turan, B Yurtsever, D Cakirsoy, S Abanuz, ...Turkish journal of haematology: official journal of Turkish Society of …, 2020202
6
2020
Yapay Zeka ve Genetik Mühendisliği
C TastanSağlık Bilimlerinde Yapay Zeka 1, 153-16, 01901
2
2019
Biological System Design Tool, Application Paper
MA Ağca, C Taştan, HS Matar, Y Tuncel, S Ataol, T Can, YA SonThe International Genetically Engineered Machine (iGEM) Competition, 20111201
1
2011
Lentiviral micro-dystrophin gene treatment into late-stage mdx mice for Duchene Muscular Dystrophy disease.
SA Eren, C Tastan, KB Karadeniz, RD Turan, D Cakirsoy, DD Kancagi, ...Current Gene Therapy, 2023202
1
2023
Gene Editing
A Ates, C Tastan, S ErmertcanThe journal: Young, open, and free! , 30-35, 2020202
1
2020
The effect of molecular genetic mechanisms on drug addiction and related new generation CRISPR gene engineering applications
E Akyürek, B Uysal, G Gülden, C TaştanGene 2, 50-60, 20220
1
2021
The Overall Consequence of Antiviral Drugs Given to Pregnant Women with COVID-19
The Overall Consequence of Antiviral Drugs Given to Pregnant Women with COVID-9G Akpinar, C TastanJ Bacteriol Parasitol. S 0, 20220
1
2021
Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application
Preliminary Report of the Academic CAR-T (ISIKOK-9) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical ApplicationE Erdoğan, K Yalçın, C Hemşinlioğlu, A Sezgin, U Seyis, DD Kancağı, ...Turkish Journal of Hematology 39 (3), 206, 2022202
1
2022

Referred From: https://scholar.google.com/citations?user=px2LTJsAAAAJ&hl=en

Cited by
Citations 329
h-index 9
i10-index 8
Recommended Journals
Open Access Journals